Lei Wang

Ghazal Mirabnahrazam, Da Ma, Cédric Beaulac et al.

Dementia of Alzheimer's Type (DAT) is a complex disorder influenced by numerous factors, but it is unclear how each factor contributes to disease progression. An in-depth examination of these factors may yield an accurate estimate of time-to-conversion to DAT for patients at various disease stages. We used 401 subjects with 63 features from MRI, genetic, and CDC (Cognitive tests, Demographic, and CSF) data modalities in the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We used a deep learning-based survival analysis model that extends the classic Cox regression model to predict time-to-conversion to DAT. Our findings showed that genetic features contributed the least to survival analysis, while CDC features contributed the most. Combining MRI and genetic features improved survival prediction over using either modality alone, but adding CDC to any combination of features only worked as well as using only CDC features. Consequently, our study demonstrated that using the current clinical procedure, which includes gathering cognitive test results, can outperform survival analysis results produced using costly genetic or CSF data.

Ayagoz Mussabayeva, Alexey Kroshnin, Anvar Kurmukov et al.

We present a method for metric optimization in the Large Deformation Diffeomorphic Metric Mapping (LDDMM) framework, by treating the induced Riemannian metric on the space of diffeomorphisms as a kernel in a machine learning context. For simplicity, we choose the kernel Fischer Linear Discriminant Analysis (KLDA) as the framework. Optimizing the kernel parameters in an Expectation-Maximization framework, we define model fidelity via the hinge loss of the decision function. The resulting algorithm optimizes the parameters of the LDDMM norm-inducing differential operator as a solution to a group-wise registration and classification problem. In practice, this may lead to a biology-aware registration, focusing its attention on the predictive task at hand such as identifying the effects of disease. We first tested our algorithm on a synthetic dataset, showing that our parameter selection improves registration quality and classification accuracy. We then tested the algorithm on 3D subcortical shapes from the Schizophrenia cohort Schizconnect. Our Schizpohrenia-Control predictive model showed significant improvement in ROC AUC compared to baseline parameters.